Ecolab (ECL) Could Be 14% Below Fair Value Following Its One Ecolab Push
Recent share performance and business scale
Ecolab (ECL) has drawn fresh investor attention after recent price moves, with the stock last closing at US$278.97. The share price is down modestly over the past week and month, but higher over the past 3 months.
The company reports annual revenue of US$16.8b and net income of US$2.1b across its water, institutional and specialty, pest elimination and life sciences operations. These figures help frame the size of the business behind the recent share performance.
Over the past year, Ecolab’s share price momentum has cooled in the short term, with the 7 day and 30 day share price returns slightly down. However, a stronger 90 day share price return of 8.14% and a 3 year total shareholder return of 58.42% point to a still supportive longer term trend.
Compare Ecolab’s recent momentum with hand picked peers by scanning 79 resilient stocks with low risk scores, which pairs resilient balance sheets with more controlled share price swings.
Ecolab’s share price has cooled a little after a strong three year run, yet analyst targets and intrinsic estimates sit higher than today’s US$278.97. How wide is that valuation gap in practice?
Most Popular Narrative: 14% Undervalued
The most followed narrative currently places Ecolab’s fair value at about $323.71, comfortably above the latest close at $278.97. That gap rests on a detailed set of growth and margin expectations that go beyond the recent share pullback.
Ecolab is focusing on expanding its One Ecolab growth initiative, aiming to capitalize on market share gains and increased value pricing. This initiative is expected to drive revenue growth and improve net margins by delivering exceptional value to customers.
Investors may be curious about the kind of revenue path this narrative assumes for Ecolab, or how much profit expansion it incorporates. The model references higher earnings along with a future earnings multiple that remains above the wider chemicals sector. The numbers behind that view are where the story becomes more detailed.
Result: Fair Value of $323.71 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, Ecolab’s story could change if softer industrial demand persists or if customers resist trade surcharges. This would pressure both revenue and the margin recovery narrative.
Find out about the key risks to this Ecolab narrative.
Another view on Ecolab’s valuation
The most popular narrative sees Ecolab as undervalued, yet the current P/E of about 37x paints a different picture. That is much higher than the US Chemicals industry on 23.2x, peers on 20.5x and the fair ratio of 24.8x, which implies meaningful valuation risk if sentiment cools.
To see how that premium multiple compares with the underlying earnings profile, review the valuation breakdown in the See what the numbers say about this price — find out in our valuation breakdown.
Next Steps
If this mix of optimism and caution around Ecolab feels familiar, that is the point. Act while the details are clear and carefully weigh the 1 key reward and 2 important warning signs.
Looking for more investment ideas beyond Ecolab?
If you like the level of detail around Ecolab, you should not stop here. Broaden your opportunity set using focused stock lists that match your style.
- Target stronger value opportunities by scanning companies that appear mispriced on quality and fundamentals with the help of 53 high quality undervalued stocks.
- Strengthen your income stream by reviewing companies with higher yields and resilient payouts through the 11 dividend fortresses.
- Raise your quality bar by filtering for companies with healthier finances and consistent fundamentals using the list of solid balance sheet and fundamentals (53 results).
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com